163 related articles for article (PubMed ID: 38732215)
21. KCTD5, a novel TRPM4-regulatory protein required for cell migration as a new predictor for breast cancer prognosis.
Rivas J; Díaz N; Silva I; Morales D; Lavanderos B; Álvarez A; Saldías MP; Pulgar E; Cruz P; Maureira D; Flores G; Colombo A; Blanco C; Contreras HR; Jaña F; Gallegos I; Concha ML; Vergara-Jaque A; Poblete H; González W; Varela D; Trimmer JS; Cáceres M; Cerda O
FASEB J; 2020 Jun; 34(6):7847-7865. PubMed ID: 32301552
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of hyperpolarization-activated cyclic nucleotide-gated channel 3 (HCN3) by specific interaction with K+ channel tetramerization domain-containing protein 3 (KCTD3).
Cao-Ehlker X; Zong X; Hammelmann V; Gruner C; Fenske S; Michalakis S; Wahl-Schott C; Biel M
J Biol Chem; 2013 Mar; 288(11):7580-7589. PubMed ID: 23382386
[TBL] [Abstract][Full Text] [Related]
23. Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits.
Schwenk J; Metz M; Zolles G; Turecek R; Fritzius T; Bildl W; Tarusawa E; Kulik A; Unger A; Ivankova K; Seddik R; Tiao JY; Rajalu M; Trojanova J; Rohde V; Gassmann M; Schulte U; Fakler B; Bettler B
Nature; 2010 May; 465(7295):231-5. PubMed ID: 20400944
[TBL] [Abstract][Full Text] [Related]
24. Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins.
Smaldone G; Pirone L; Balasco N; Di Gaetano S; Pedone EM; Vitagliano L
PLoS One; 2015; 10(5):e0126808. PubMed ID: 25974686
[TBL] [Abstract][Full Text] [Related]
25. Knockout of CTNNB1 by CRISPR-Cas9 technology inhibits cell proliferation through the Wnt/β-catenin signaling pathway.
Guan L; Zhu S; Han Y; Yang C; Liu Y; Qiao L; Li X; Li H; Lin J
Biotechnol Lett; 2018 Mar; 40(3):501-508. PubMed ID: 29249062
[TBL] [Abstract][Full Text] [Related]
26. [Effect of Knocking Out
Man JC; Cheng J; Zhao L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):52-56. PubMed ID: 38387899
[TBL] [Abstract][Full Text] [Related]
27. The Combinational Use of CRISPR/Cas9 and Targeted Toxin Technology Enables Efficient Isolation of Bi-Allelic Knockout Non-Human Mammalian Clones.
Watanabe S; Sakurai T; Nakamura S; Miyoshi K; Sato M
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617297
[TBL] [Abstract][Full Text] [Related]
28. Generation of TGFBI knockout ABCG2+/ABCB5+ double-positive limbal epithelial stem cells by CRISPR/Cas9-mediated genome editing.
Kim EK; Kim S; Maeng YS
PLoS One; 2019; 14(2):e0211864. PubMed ID: 30753226
[TBL] [Abstract][Full Text] [Related]
29. RNA-seq Analysis of the SCN1A-KO Model based on CRISPR/Cas9 Genome Editing Technology.
Shi X; He W; Guo S; Zhang B; Ren S; Liu K; Sun T; Cui J
Neuroscience; 2019 Feb; 398():1-11. PubMed ID: 30529264
[TBL] [Abstract][Full Text] [Related]
30. A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3.
Balasco N; Esposito L; Smaldone G; Salvatore M; Vitagliano L
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339159
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas9 Gene Editing of Human Histone H2A Variant H2AX and MacroH2A.
Leung JWC; Emery LE; Miller KM
Methods Mol Biol; 2018; 1832():255-269. PubMed ID: 30073532
[TBL] [Abstract][Full Text] [Related]
32. Knockout of
Malek N; Mrówczyńska E; Michrowska A; Mazurkiewicz E; Pavlyk I; Mazur AJ
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326615
[TBL] [Abstract][Full Text] [Related]
33. Molecular organization of the cullin E3 ligase adaptor KCTD11.
Correale S; Pirone L; Di Marcotullio L; De Smaele E; Greco A; Mazzà D; Moretti M; Alterio V; Vitagliano L; Di Gaetano S; Gulino A; Pedone EM
Biochimie; 2011 Apr; 93(4):715-24. PubMed ID: 21237243
[TBL] [Abstract][Full Text] [Related]
34. Construction of Traf3 knockout liver cancer cell line using CRISPR/Cas9 system.
Hu W; Guo G; Chi Y; Li F
J Cell Biochem; 2019 Sep; 120(9):14908-14915. PubMed ID: 31016787
[TBL] [Abstract][Full Text] [Related]
35. Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance.
Bowden AR; Morales-Juarez DA; Sczaniecka-Clift M; Agudo MM; Lukashchuk N; Thomas JC; Jackson SP
Elife; 2020 May; 9():. PubMed ID: 32441252
[TBL] [Abstract][Full Text] [Related]
36. [Construction of a stable
Zhou Z; Lü X; Zhu L; Zhou J; Huang H; Zhang C; Liu X
Sheng Wu Gong Cheng Xue Bao; 2022 Mar; 38(3):1074-1085. PubMed ID: 35355475
[TBL] [Abstract][Full Text] [Related]
37. CRISPR-Cas9 editing of non-coding genomic loci as a means of controlling gene expression in the sea urchin.
Pieplow A; Dastaw M; Sakuma T; Sakamoto N; Yamamoto T; Yajima M; Oulhen N; Wessel GM
Dev Biol; 2021 Apr; 472():85-97. PubMed ID: 33482173
[TBL] [Abstract][Full Text] [Related]
38. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of KCTD family genes associated with hypoxic microenvironment and immune infiltration in lung adenocarcinoma.
Shi YX; Zhang WD; Dai PH; Deng J; Tan LH
Sci Rep; 2022 Jun; 12(1):9938. PubMed ID: 35705627
[TBL] [Abstract][Full Text] [Related]
40. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
